Genotyping of suspected partial hydatidiform moles - our experiences and future directions.

IF 2.7 4区 医学 Q3 ONCOLOGY
Pathology & Oncology Research Pub Date : 2026-05-25 eCollection Date: 2026-01-01 DOI:10.3389/pore.2026.1612410
Lajos Gergely, Vanda Repiska, Juraj Hutnik, Natalia Andova, Lubica Milosovicova, Miroslav Korbel, Liam McCullough, Alexandra Kristufkova, Ludovit Danihel, Helena Gbelcova, Petra Priscakova
{"title":"Genotyping of suspected partial hydatidiform moles - our experiences and future directions.","authors":"Lajos Gergely, Vanda Repiska, Juraj Hutnik, Natalia Andova, Lubica Milosovicova, Miroslav Korbel, Liam McCullough, Alexandra Kristufkova, Ludovit Danihel, Helena Gbelcova, Petra Priscakova","doi":"10.3389/pore.2026.1612410","DOIUrl":null,"url":null,"abstract":"<p><p>This brief research report summarizes our experience with the molecular differential diagnosis of clinically or pathologically suspected partial hydatidiform moles and discusses practical diagnostic options when economic resources or laboratory infrastructure are limited. We analyzed the genome composition of 68 suspected cases using short tandem repeat genotyping based on quantitative fluorescent PCR and fragmentation analysis. Genetic testing excluded a partial mole in 35 cases (51%) by demonstrating a diploid or monogynic monoandric diploid genome, while in 33 cases (49%) a partial mole was confirmed through identification of diandric triploidy (31 cases) or triandric tetraploidy (2 cases). No instances of digynic triploidy were detected in this cohort. Our findings indicate that, in the absence of access to a DNA laboratory, most suspected partial moles can still be accurately evaluated using ploidy assessment by more widely available methods, such as fluorescent <i>in situ</i> hybridization, DNA flow cytometry, or conventional karyotyping, given the apparent rarity of digynic triploidy among these cases.</p>","PeriodicalId":19981,"journal":{"name":"Pathology & Oncology Research","volume":"32 ","pages":"1612410"},"PeriodicalIF":2.7000,"publicationDate":"2026-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13243142/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pathology & Oncology Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/pore.2026.1612410","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

This brief research report summarizes our experience with the molecular differential diagnosis of clinically or pathologically suspected partial hydatidiform moles and discusses practical diagnostic options when economic resources or laboratory infrastructure are limited. We analyzed the genome composition of 68 suspected cases using short tandem repeat genotyping based on quantitative fluorescent PCR and fragmentation analysis. Genetic testing excluded a partial mole in 35 cases (51%) by demonstrating a diploid or monogynic monoandric diploid genome, while in 33 cases (49%) a partial mole was confirmed through identification of diandric triploidy (31 cases) or triandric tetraploidy (2 cases). No instances of digynic triploidy were detected in this cohort. Our findings indicate that, in the absence of access to a DNA laboratory, most suspected partial moles can still be accurately evaluated using ploidy assessment by more widely available methods, such as fluorescent in situ hybridization, DNA flow cytometry, or conventional karyotyping, given the apparent rarity of digynic triploidy among these cases.

疑似部分包体痣的基因分型——我们的经验和未来的方向。
这篇简短的研究报告总结了我们在临床上或病理上怀疑部分葡萄胎的分子鉴别诊断的经验,并讨论了当经济资源或实验室基础设施有限时的实际诊断选择。采用定量荧光PCR和片段化分析的短串联重复基因分型方法对68例疑似病例的基因组组成进行了分析。基因检测35例(51%)通过二倍体或单雄性二倍体基因组排除部分痣,33例(49%)通过双雄性三倍体(31例)或三雄性四倍体(2例)确认部分痣。在该队列中未发现双异型三倍体。我们的研究结果表明,在没有进入DNA实验室的情况下,大多数可疑的部分痣仍然可以通过更广泛可用的方法,如荧光原位杂交,DNA流式细胞术或常规核型,使用倍性评估来准确评估,因为这些病例中明显罕见的双异体三倍体。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.30
自引率
0.00%
发文量
134
审稿时长
4-8 weeks
期刊介绍: Pathology & Oncology Research (POR) is an interdisciplinary Journal at the interface of pathology and oncology including the preclinical and translational research, diagnostics and therapy. Furthermore, POR is an international forum for the rapid communication of reviews, original research, critical and topical reports with excellence and novelty. Published quarterly, POR is dedicated to keeping scientists informed of developments on the selected biomedical fields bridging the gap between basic research and clinical medicine. It is a special aim for POR to promote pathological and oncological publishing activity of colleagues in the Central and East European region. The journal will be of interest to pathologists, and a broad range of experimental and clinical oncologists, and related experts. POR is supported by an acknowledged international advisory board and the Arányi Fundation for modern pathology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书